A Study of the Efficacy and Safety of MEDI7352 in Participants with Painful Osteoarthritis of the Knee

Trial Identifier: D5680C00003
Sponsor: AstraZeneca
Start Date: October 2021
Primary Completion Date: August 2023
Study Completion Date: August 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Afrikaans Translation
Danish Translation
German Translation
Estonian Translation
Polish Translation
Russian (Estonia) Translation
Spanish Translation

Trial Locations

Country Location
DE Bad Doberan, DE, 18209
DK Frederiksberg, DK, 2000
EE Tallinn, EE, 10117
EE Tartu, EE, 50708
ES La Coruña, ES, 15006
ES Malaga, ES, 29010
ES Sabadell, ES, 08208
ES Santiago de Compostela, ES, 15705
ES Santiago de Compostela, ES, 15702
ES Santiago de Compostela-Coruña, ES, 15706
ES Valencia, ES, 46010
GB Corby, GB, NN18 9EZ
GB Enfield, GB, EN3 4GS
GB Glasgow, GB, G51 4TF
GB High Wycombe, GB, HP11 2QW
GB Leeds, GB, LS7 4SA
GB Northwich, GB, CW9 7LS
GB Northwood, GB, HA6 2RN
GB Orpington, GB, BR5 3QG
GB Preston, GB, PR2 9QB
GB Salford, GB, M6 8HD
GB Shipley, GB, BD18 3SA
PL Bialystok, PL, 15-897
PL Białystok, PL, 15-351
PL Elblag, PL, 82-300
PL Gdynia, PL, 81-338
PL Lublin, PL, 20-607
PL Poznan, PL, 61-113
PL Toruń, PL, 87-100
PL Warszawa, PL, 00-874
PL Zamosc, PL, 22-400